table of content
1 Introduction to Research & Analysis Reports
1.1 Cancer Tumor Profiling Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Tumor Profiling Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Tumor Profiling Overall Market Size
2.1 Global Cancer Tumor Profiling Market Size: 2022 VS 2030
2.2 Global Cancer Tumor Profiling Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Tumor Profiling Players in Global Market
3.2 Top Global Cancer Tumor Profiling Companies Ranked by Revenue
3.3 Global Cancer Tumor Profiling Revenue by Companies
3.4 Top 3 and Top 5 Cancer Tumor Profiling Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Tumor Profiling Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Tumor Profiling Players in Global Market
3.6.1 List of Global Tier 1 Cancer Tumor Profiling Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Tumor Profiling Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Tumor Profiling Market Size Markets, 2022 & 2030
4.1.2 Next-generation Sequencing (NGS)
4.1.3 Polymerase Chain Reaction (PCR)
4.1.4 Immunohistochemistry (IHC)
4.1.5 In Situ Hybridization (ISH)
4.1.6 Microarray
4.1.7 Others
4.2 By Type - Global Cancer Tumor Profiling Revenue & Forecasts
4.2.1 By Type - Global Cancer Tumor Profiling Revenue, 2018-2023
4.2.2 By Type - Global Cancer Tumor Profiling Revenue, 2024-2030
4.2.3 By Type - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Tumor Profiling Market Size, 2022 & 2030
5.1.2 Personalized Medicine
5.1.3 Diagnostics
5.1.4 Biomarker Discovery
5.1.5 Prognostics
5.1.6 Research Applications
5.2 By Application - Global Cancer Tumor Profiling Revenue & Forecasts
5.2.1 By Application - Global Cancer Tumor Profiling Revenue, 2018-2023
5.2.2 By Application - Global Cancer Tumor Profiling Revenue, 2024-2030
5.2.3 By Application - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Tumor Profiling Market Size, 2022 & 2030
6.2 By Region - Global Cancer Tumor Profiling Revenue & Forecasts
6.2.1 By Region - Global Cancer Tumor Profiling Revenue, 2018-2023
6.2.2 By Region - Global Cancer Tumor Profiling Revenue, 2024-2030
6.2.3 By Region - Global Cancer Tumor Profiling Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cancer Tumor Profiling Revenue, 2018-2030
6.3.2 US Cancer Tumor Profiling Market Size, 2018-2030
6.3.3 Canada Cancer Tumor Profiling Market Size, 2018-2030
6.3.4 Mexico Cancer Tumor Profiling Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Tumor Profiling Revenue, 2018-2030
6.4.2 Germany Cancer Tumor Profiling Market Size, 2018-2030
6.4.3 France Cancer Tumor Profiling Market Size, 2018-2030
6.4.4 U.K. Cancer Tumor Profiling Market Size, 2018-2030
6.4.5 Italy Cancer Tumor Profiling Market Size, 2018-2030
6.4.6 Russia Cancer Tumor Profiling Market Size, 2018-2030
6.4.7 Nordic Countries Cancer Tumor Profiling Market Size, 2018-2030
6.4.8 Benelux Cancer Tumor Profiling Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Tumor Profiling Revenue, 2018-2030
6.5.2 China Cancer Tumor Profiling Market Size, 2018-2030
6.5.3 Japan Cancer Tumor Profiling Market Size, 2018-2030
6.5.4 South Korea Cancer Tumor Profiling Market Size, 2018-2030
6.5.5 Southeast Asia Cancer Tumor Profiling Market Size, 2018-2030
6.5.6 India Cancer Tumor Profiling Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cancer Tumor Profiling Revenue, 2018-2030
6.6.2 Brazil Cancer Tumor Profiling Market Size, 2018-2030
6.6.3 Argentina Cancer Tumor Profiling Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Tumor Profiling Revenue, 2018-2030
6.7.2 Turkey Cancer Tumor Profiling Market Size, 2018-2030
6.7.3 Israel Cancer Tumor Profiling Market Size, 2018-2030
6.7.4 Saudi Arabia Cancer Tumor Profiling Market Size, 2018-2030
6.7.5 UAE Cancer Tumor Profiling Market Size, 2018-2030
7 Cancer Tumor Profiling Companies Profiles
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Company Summary
7.1.2 Qiagen N.V. Business Overview
7.1.3 Qiagen N.V. Cancer Tumor Profiling Major Product Offerings
7.1.4 Qiagen N.V. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.1.5 Qiagen N.V. Key News & Latest Developments
7.2 Roche Molecular Systems Inc.
7.2.1 Roche Molecular Systems Inc. Company Summary
7.2.2 Roche Molecular Systems Inc. Business Overview
7.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Major Product Offerings
7.2.4 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.2.5 Roche Molecular Systems Inc. Key News & Latest Developments
7.3 Abott Molecular
7.3.1 Abott Molecular Company Summary
7.3.2 Abott Molecular Business Overview
7.3.3 Abott Molecular Cancer Tumor Profiling Major Product Offerings
7.3.4 Abott Molecular Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.3.5 Abott Molecular Key News & Latest Developments
7.4 Illumina Inc.
7.4.1 Illumina Inc. Company Summary
7.4.2 Illumina Inc. Business Overview
7.4.3 Illumina Inc. Cancer Tumor Profiling Major Product Offerings
7.4.4 Illumina Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.4.5 Illumina Inc. Key News & Latest Developments
7.5 NeoGenomics Laboratories
7.5.1 NeoGenomics Laboratories Company Summary
7.5.2 NeoGenomics Laboratories Business Overview
7.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Major Product Offerings
7.5.4 NeoGenomics Laboratories Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.5.5 NeoGenomics Laboratories Key News & Latest Developments
7.6 HTG Molecular Diagnostic
7.6.1 HTG Molecular Diagnostic Company Summary
7.6.2 HTG Molecular Diagnostic Business Overview
7.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Major Product Offerings
7.6.4 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.6.5 HTG Molecular Diagnostic Key News & Latest Developments
7.7 Genomic Health Inc.
7.7.1 Genomic Health Inc. Company Summary
7.7.2 Genomic Health Inc. Business Overview
7.7.3 Genomic Health Inc. Cancer Tumor Profiling Major Product Offerings
7.7.4 Genomic Health Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.7.5 Genomic Health Inc. Key News & Latest Developments
7.8 Hologic Gen-Probe
7.8.1 Hologic Gen-Probe Company Summary
7.8.2 Hologic Gen-Probe Business Overview
7.8.3 Hologic Gen-Probe Cancer Tumor Profiling Major Product Offerings
7.8.4 Hologic Gen-Probe Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.8.5 Hologic Gen-Probe Key News & Latest Developments
7.9 BD Biosciences
7.9.1 BD Biosciences Company Summary
7.9.2 BD Biosciences Business Overview
7.9.3 BD Biosciences Cancer Tumor Profiling Major Product Offerings
7.9.4 BD Biosciences Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.9.5 BD Biosciences Key News & Latest Developments
7.10 Siemens Healthineers
7.10.1 Siemens Healthineers Company Summary
7.10.2 Siemens Healthineers Business Overview
7.10.3 Siemens Healthineers Cancer Tumor Profiling Major Product Offerings
7.10.4 Siemens Healthineers Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.10.5 Siemens Healthineers Key News & Latest Developments
7.11 Claris Life Sciences
7.11.1 Claris Life Sciences Company Summary
7.11.2 Claris Life Sciences Business Overview
7.11.3 Claris Life Sciences Cancer Tumor Profiling Major Product Offerings
7.11.4 Claris Life Sciences Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.11.5 Claris Life Sciences Key News & Latest Developments
7.12 Personal Genome Diagnostics, Inc.
7.12.1 Personal Genome Diagnostics, Inc. Company Summary
7.12.2 Personal Genome Diagnostics, Inc. Business Overview
7.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Major Product Offerings
7.12.4 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.12.5 Personal Genome Diagnostics, Inc. Key News & Latest Developments
7.13 Perthera, Inc.
7.13.1 Perthera, Inc. Company Summary
7.13.2 Perthera, Inc. Business Overview
7.13.3 Perthera, Inc. Cancer Tumor Profiling Major Product Offerings
7.13.4 Perthera, Inc. Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.13.5 Perthera, Inc. Key News & Latest Developments
7.14 Foundation Medicine, Inc
7.14.1 Foundation Medicine, Inc Company Summary
7.14.2 Foundation Medicine, Inc Business Overview
7.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Major Product Offerings
7.14.4 Foundation Medicine, Inc Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.14.5 Foundation Medicine, Inc Key News & Latest Developments
7.15 V., Strand
7.15.1 V., Strand Company Summary
7.15.2 V., Strand Business Overview
7.15.3 V., Strand Cancer Tumor Profiling Major Product Offerings
7.15.4 V., Strand Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.15.5 V., Strand Key News & Latest Developments
7.16 ApoCell
7.16.1 ApoCell Company Summary
7.16.2 ApoCell Business Overview
7.16.3 ApoCell Cancer Tumor Profiling Major Product Offerings
7.16.4 ApoCell Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.16.5 ApoCell Key News & Latest Developments
7.17 Contextual Genomics
7.17.1 Contextual Genomics Company Summary
7.17.2 Contextual Genomics Business Overview
7.17.3 Contextual Genomics Cancer Tumor Profiling Major Product Offerings
7.17.4 Contextual Genomics Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.17.5 Contextual Genomics Key News & Latest Developments
7.18 Agendia
7.18.1 Agendia Company Summary
7.18.2 Agendia Business Overview
7.18.3 Agendia Cancer Tumor Profiling Major Product Offerings
7.18.4 Agendia Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.18.5 Agendia Key News & Latest Developments
7.19 GenScript
7.19.1 GenScript Company Summary
7.19.2 GenScript Business Overview
7.19.3 GenScript Cancer Tumor Profiling Major Product Offerings
7.19.4 GenScript Cancer Tumor Profiling Revenue in Global Market (2018-2023)
7.19.5 GenScript Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
